

share
Stirocainide CAS NO 78372-27-7
Unit Price:
CAS No.:78372-27-7
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Stirocainide is a synthetic organic compound with specific pharmacological activity. This compound is valued for its role as a key intermediate in the research and development of active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical manufacturers and research institutions engaged in the synthesis of novel therapeutic agents, particularly in the cardiovascular and neurological domains.
Application
- Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of proprietary drug candidates.
- Cardiovascular Research: Used in the development and study of compounds targeting specific ion channels or receptors.
- Neurological Research: Applied in the synthesis of molecules for investigating central nervous system (CNS) disorders.
- Chemical Reference Standard: Employed as a high-purity standard for analytical method development and quality control in laboratories.
- Process Development: Utilized by process chemists to optimize scalable and cost-effective synthetic routes for target molecules.
- Academic Research: Supports investigative studies in medicinal chemistry and pharmacology at universities and research institutes.
Basic Information
| Product Name | Stirocainide |
| CAS No. | 78372-27-7 |
| Molecular Formula | C18H24N2O2 |
| Molecular Weight | 300.40 g/mol |
| Synonyms | Stirocainide; 1-(2,6-Dimethylphenoxy)-2-(1-pyrrolidinyl)propanamine; 2-(1-Pyrrolidinyl)-1-(2,6-xylyloxy)propylamine; McN-4097; McN 4097; McN4097; (RS)-Stirocainide |
| EINECS | Contact for details |
Quality Control
Our Stirocainide is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to reference spectrum |
| Identification (HPLC) | Retention time matches reference standard |
| Assay (HPLC) | ≥ 98.0% |
| Related Substances (HPLC) | Total impurities ≤ 2.0% Any single impurity ≤ 1.0% |
| Residual Solvents (GC) | Complies with ICH Q3C guidelines |
| Loss on Drying | ≤ 0.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Quindonium Bromide CAS NO 130-81-4


Carcainium Chloride CAS NO 1042-42-8


Diarbarone CAS NO 1233-70-1


Hydroquinidine Hydrochloride CAS NO 1476-98-8


Pyrinoline CAS NO 1740-22-3


Novoimanine CAS NO 11004-82-3


Amiodarone CAS NO 1951-25-3


Asparkam CAS NO 14842-81-0


Hydroxyquinidine Gluconate CAS NO 18253-58-2


Amiodarone Hydrochloride CAS NO 19774-82-4


Cibenzoline Succinate CAS NO 100678-32-8


(-)-(S)-Cibenzoline CAS NO 103419-18-7


Bidisomide CAS NO 103810-45-3


(R)-Propafenone CAS NO 107381-31-7


(S)-Propafenone CAS NO 107381-32-8


(R)-(+)-Propafenone Hydrochloride CAS NO 107381-35-1


(S)-(-)-Propafenone Hydrochloride CAS NO 107381-36-2


(17R,21-Alpha)-17,21-Dihydroxy-4-(2-Propenyl)Ajmalanium Bromide CAS NO 107870-71-3


Selodenoson CAS NO 110299-05-3


1,2-Benzenediol, 4-[2-[(1-Methylethyl)Amino]Propyl]- (9Ci) CAS NO 114020-48-3
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






